nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—Raltitrexed—Pemetrexed—lung cancer	0.0149	0.765	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—respiratory system—lung cancer	0.00621	0.117	CbGeAlD
Fluocinolone Acetonide—SERPINA6—respiratory system—lung cancer	0.00618	0.116	CbGeAlD
Fluocinolone Acetonide—Amcinonide—ANXA1—lung cancer	0.0055	0.393	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—bronchus—lung cancer	0.00511	0.0959	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—trachea—lung cancer	0.00459	0.0861	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Raltitrexed—Methotrexate—lung cancer	0.00459	0.235	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—bone marrow—lung cancer	0.00364	0.0683	CbGeAlD
Fluocinolone Acetonide—SERPINA6—bone marrow—lung cancer	0.00362	0.068	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lung—lung cancer	0.0033	0.0619	CbGeAlD
Fluocinolone Acetonide—SERPINA6—lung—lung cancer	0.00328	0.0616	CbGeAlD
Fluocinolone Acetonide—NR3C1—respiratory system—lung cancer	0.00271	0.0508	CbGeAlD
Fluocinolone Acetonide—NR3C1—epithelium—lung cancer	0.00226	0.0425	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lymph node—lung cancer	0.00225	0.0423	CbGeAlD
Fluocinolone Acetonide—NR3C1—bronchus—lung cancer	0.00223	0.0418	CbGeAlD
Fluocinolone Acetonide—NR3C1—trachea—lung cancer	0.002	0.0376	CbGeAlD
Fluocinolone Acetonide—NR3C1—cardiac atrium—lung cancer	0.00188	0.0353	CbGeAlD
Fluocinolone Acetonide—Dexamethasone—ANXA1—lung cancer	0.00173	0.123	CrCbGaD
Fluocinolone Acetonide—NR3C1—bone marrow—lung cancer	0.00159	0.0298	CbGeAlD
Fluocinolone Acetonide—NR3C1—lung—lung cancer	0.00144	0.027	CbGeAlD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A1—lung cancer	0.000992	0.0708	CrCbGaD
Fluocinolone Acetonide—NR3C1—lymph node—lung cancer	0.000984	0.0185	CbGeAlD
Fluocinolone Acetonide—Prednisolone—CYP2A6—lung cancer	0.00093	0.0664	CrCbGaD
Fluocinolone Acetonide—Erythema—Gemcitabine—lung cancer	0.000768	0.00132	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Vinorelbine—lung cancer	0.000765	0.00131	CcSEcCtD
Fluocinolone Acetonide—Back pain—Irinotecan—lung cancer	0.000763	0.00131	CcSEcCtD
Fluocinolone Acetonide—Back pain—Gemcitabine—lung cancer	0.000743	0.00128	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Cisplatin—lung cancer	0.000741	0.00127	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Paclitaxel—lung cancer	0.000741	0.00127	CcSEcCtD
Fluocinolone Acetonide—Nausea—Teniposide—lung cancer	0.000731	0.00126	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Cisplatin—lung cancer	0.000727	0.00125	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Paclitaxel—lung cancer	0.000726	0.00125	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Topotecan—lung cancer	0.000721	0.00124	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Doxorubicin—lung cancer	0.000719	0.00123	CcSEcCtD
Fluocinolone Acetonide—Erythema—Cisplatin—lung cancer	0.000716	0.00123	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Cisplatin—lung cancer	0.000716	0.00123	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Erlotinib—lung cancer	0.000714	0.00123	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Paclitaxel—lung cancer	0.000712	0.00122	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000711	0.00122	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Irinotecan—lung cancer	0.000709	0.00122	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Etoposide—lung cancer	0.000704	0.00121	CcSEcCtD
Fluocinolone Acetonide—Infestation—Docetaxel—lung cancer	0.000698	0.0012	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Docetaxel—lung cancer	0.000698	0.0012	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vinblastine—lung cancer	0.000692	0.00119	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Paclitaxel—lung cancer	0.00069	0.00119	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Methotrexate—lung cancer	0.000688	0.00118	CcSEcCtD
Fluocinolone Acetonide—Cough—Irinotecan—lung cancer	0.000688	0.00118	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Etoposide—lung cancer	0.000679	0.00117	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Cisplatin—lung cancer	0.000675	0.00116	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000674	0.00116	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Topotecan—lung cancer	0.000672	0.00115	CcSEcCtD
Fluocinolone Acetonide—Cough—Gemcitabine—lung cancer	0.00067	0.00115	CcSEcCtD
Fluocinolone Acetonide—Pain—Vinorelbine—lung cancer	0.000667	0.00115	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Etoposide—lung cancer	0.000666	0.00114	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Paclitaxel—lung cancer	0.000666	0.00114	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Gemcitabine—lung cancer	0.000654	0.00112	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Paclitaxel—lung cancer	0.000653	0.00112	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Paclitaxel—lung cancer	0.000647	0.00111	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Topotecan—lung cancer	0.000645	0.00111	CcSEcCtD
Fluocinolone Acetonide—Oedema—Irinotecan—lung cancer	0.000644	0.00111	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Paclitaxel—lung cancer	0.000643	0.0011	CcSEcCtD
Fluocinolone Acetonide—Erythema—Paclitaxel—lung cancer	0.000643	0.0011	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vinblastine—lung cancer	0.000643	0.0011	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Etoposide—lung cancer	0.000642	0.0011	CcSEcCtD
Fluocinolone Acetonide—Infection—Irinotecan—lung cancer	0.000639	0.0011	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Erlotinib—lung cancer	0.000639	0.0011	CcSEcCtD
Fluocinolone Acetonide—Back pain—Etoposide—lung cancer	0.000634	0.00109	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Irinotecan—lung cancer	0.000631	0.00108	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Paclitaxel—lung cancer	0.00063	0.00108	CcSEcCtD
Fluocinolone Acetonide—Eczema—Doxorubicin—lung cancer	0.000629	0.00108	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Docetaxel—lung cancer	0.000628	0.00108	CcSEcCtD
Fluocinolone Acetonide—Oedema—Gemcitabine—lung cancer	0.000627	0.00108	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Doxorubicin—lung cancer	0.000626	0.00107	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Topotecan—lung cancer	0.000624	0.00107	CcSEcCtD
Fluocinolone Acetonide—Infection—Gemcitabine—lung cancer	0.000623	0.00107	CcSEcCtD
Fluocinolone Acetonide—Back pain—Paclitaxel—lung cancer	0.000622	0.00107	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vinblastine—lung cancer	0.000621	0.00107	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Erlotinib—lung cancer	0.000618	0.00106	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Vinorelbine—lung cancer	0.000617	0.00106	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—lung cancer	0.000616	0.044	CrCbGaD
Fluocinolone Acetonide—Connective tissue disorder—Docetaxel—lung cancer	0.000615	0.00106	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Gemcitabine—lung cancer	0.000615	0.00106	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Paclitaxel—lung cancer	0.000606	0.00104	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Docetaxel—lung cancer	0.000603	0.00104	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Topotecan—lung cancer	0.000603	0.00104	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vinblastine—lung cancer	0.000597	0.00103	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Erlotinib—lung cancer	0.000597	0.00102	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Etoposide—lung cancer	0.000589	0.00101	CcSEcCtD
Fluocinolone Acetonide—Headache—Vinblastine—lung cancer	0.000588	0.00101	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Docetaxel—lung cancer	0.000585	0.001	CcSEcCtD
Fluocinolone Acetonide—Oedema—Cisplatin—lung cancer	0.000584	0.001	CcSEcCtD
Fluocinolone Acetonide—Infection—Cisplatin—lung cancer	0.000581	0.000997	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Topotecan—lung cancer	0.00058	0.000996	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Doxorubicin—lung cancer	0.000579	0.000994	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Paclitaxel—lung cancer	0.000578	0.000992	CcSEcCtD
Fluocinolone Acetonide—Rash—Topotecan—lung cancer	0.000575	0.000988	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vinorelbine—lung cancer	0.000575	0.000987	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Topotecan—lung cancer	0.000575	0.000987	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Erlotinib—lung cancer	0.000574	0.000985	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Cisplatin—lung cancer	0.000573	0.000984	CcSEcCtD
Fluocinolone Acetonide—Cough—Etoposide—lung cancer	0.000572	0.000983	CcSEcCtD
Fluocinolone Acetonide—Headache—Topotecan—lung cancer	0.000571	0.000981	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000571	0.000981	CcSEcCtD
Fluocinolone Acetonide—Rash—Erlotinib—lung cancer	0.000569	0.000977	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Erlotinib—lung cancer	0.000569	0.000976	CcSEcCtD
Fluocinolone Acetonide—Headache—Erlotinib—lung cancer	0.000565	0.000971	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Doxorubicin—lung cancer	0.000565	0.00097	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Doxorubicin—lung cancer	0.000565	0.00097	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Docetaxel—lung cancer	0.000564	0.000969	CcSEcCtD
Fluocinolone Acetonide—Cough—Paclitaxel—lung cancer	0.000561	0.000964	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vinblastine—lung cancer	0.000558	0.000958	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000556	0.000954	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Docetaxel—lung cancer	0.000553	0.00095	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Vinorelbine—lung cancer	0.000552	0.000948	CcSEcCtD
Fluocinolone Acetonide—Pain—Irinotecan—lung cancer	0.00055	0.000945	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Docetaxel—lung cancer	0.000549	0.000942	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Paclitaxel—lung cancer	0.000548	0.00094	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Docetaxel—lung cancer	0.000545	0.000936	CcSEcCtD
Fluocinolone Acetonide—Erythema—Docetaxel—lung cancer	0.000545	0.000936	CcSEcCtD
Fluocinolone Acetonide—Nausea—Topotecan—lung cancer	0.000542	0.00093	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000541	0.000929	CcSEcCtD
Fluocinolone Acetonide—Pain—Gemcitabine—lung cancer	0.000536	0.00092	CcSEcCtD
Fluocinolone Acetonide—Nausea—Erlotinib—lung cancer	0.000536	0.00092	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vinorelbine—lung cancer	0.000534	0.000917	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Docetaxel—lung cancer	0.000534	0.000917	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000532	0.000914	CcSEcCtD
Fluocinolone Acetonide—Infection—Etoposide—lung cancer	0.000532	0.000913	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP2A6—lung cancer	0.00053	0.0378	CrCbGaD
Fluocinolone Acetonide—Back pain—Docetaxel—lung cancer	0.000527	0.000905	CcSEcCtD
Fluocinolone Acetonide—Oedema—Paclitaxel—lung cancer	0.000525	0.000901	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Methotrexate—lung cancer	0.000524	0.0009	CcSEcCtD
Fluocinolone Acetonide—Infection—Paclitaxel—lung cancer	0.000521	0.000895	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vinorelbine—lung cancer	0.000516	0.000886	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Paclitaxel—lung cancer	0.000515	0.000884	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Irinotecan—lung cancer	0.000509	0.000874	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Doxorubicin—lung cancer	0.000505	0.000867	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000504	0.000866	CcSEcCtD
Fluocinolone Acetonide—Infestation—Methotrexate—lung cancer	0.000503	0.000863	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Methotrexate—lung cancer	0.000503	0.000863	CcSEcCtD
Fluocinolone Acetonide—Pain—Cisplatin—lung cancer	0.0005	0.000858	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vinorelbine—lung cancer	0.000496	0.000852	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Gemcitabine—lung cancer	0.000496	0.000851	CcSEcCtD
Fluocinolone Acetonide—Rash—Vinorelbine—lung cancer	0.000492	0.000845	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vinorelbine—lung cancer	0.000492	0.000844	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—lung cancer	0.000491	0.0351	CrCbGaD
Fluocinolone Acetonide—Headache—Vinorelbine—lung cancer	0.000489	0.000839	CcSEcCtD
Fluocinolone Acetonide—Influenza—Doxorubicin—lung cancer	0.000488	0.000838	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—lung cancer	0.000487	0.0348	CrCbGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000478	0.000821	CcSEcCtD
Fluocinolone Acetonide—Cough—Docetaxel—lung cancer	0.000476	0.000817	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Irinotecan—lung cancer	0.000474	0.000814	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—ABCG2—lung cancer	0.000474	0.0338	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Docetaxel—lung cancer	0.000464	0.000797	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vinorelbine—lung cancer	0.000464	0.000796	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Etoposide—lung cancer	0.000462	0.000794	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Cisplatin—lung cancer	0.000462	0.000793	CcSEcCtD
Fluocinolone Acetonide—Pain—Etoposide—lung cancer	0.000458	0.000786	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000454	0.000779	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000453	0.000778	CcSEcCtD
Fluocinolone Acetonide—Pain—Paclitaxel—lung cancer	0.000449	0.000771	CcSEcCtD
Fluocinolone Acetonide—Oedema—Docetaxel—lung cancer	0.000445	0.000764	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Gemcitabine—lung cancer	0.000444	0.000762	CcSEcCtD
Fluocinolone Acetonide—Infection—Docetaxel—lung cancer	0.000442	0.000759	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Irinotecan—lung cancer	0.00044	0.000756	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Docetaxel—lung cancer	0.000436	0.000749	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—lung cancer	0.000435	0.000747	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—lung cancer	0.000435	0.000747	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Methotrexate—lung cancer	0.000435	0.000747	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Cisplatin—lung cancer	0.000431	0.000739	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Gemcitabine—lung cancer	0.000429	0.000736	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Irinotecan—lung cancer	0.000426	0.000731	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Etoposide—lung cancer	0.000423	0.000727	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Methotrexate—lung cancer	0.000422	0.000724	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Paclitaxel—lung cancer	0.000415	0.000712	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Irinotecan—lung cancer	0.000409	0.000703	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—lung cancer	0.000408	0.000701	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Methotrexate—lung cancer	0.000407	0.000698	CcSEcCtD
Fluocinolone Acetonide—Rash—Irinotecan—lung cancer	0.000406	0.000697	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Irinotecan—lung cancer	0.000405	0.000696	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000405	0.000696	CcSEcCtD
Fluocinolone Acetonide—Headache—Irinotecan—lung cancer	0.000403	0.000692	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Cisplatin—lung cancer	0.0004	0.000686	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Methotrexate—lung cancer	0.000399	0.000685	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—lung cancer	0.000399	0.0285	CrCbGaD
Fluocinolone Acetonide—Vomiting—Gemcitabine—lung cancer	0.000399	0.000684	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Methotrexate—lung cancer	0.000395	0.000679	CcSEcCtD
Fluocinolone Acetonide—Rash—Gemcitabine—lung cancer	0.000395	0.000679	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Gemcitabine—lung cancer	0.000395	0.000678	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Etoposide—lung cancer	0.000394	0.000677	CcSEcCtD
Fluocinolone Acetonide—Erythema—Methotrexate—lung cancer	0.000393	0.000675	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Methotrexate—lung cancer	0.000393	0.000675	CcSEcCtD
Fluocinolone Acetonide—Headache—Gemcitabine—lung cancer	0.000393	0.000674	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—lung cancer	0.000392	0.000673	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Paclitaxel—lung cancer	0.000387	0.000664	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Methotrexate—lung cancer	0.000385	0.000661	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000384	0.000659	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—lung cancer	0.000384	0.000659	CcSEcCtD
Fluocinolone Acetonide—Nausea—Irinotecan—lung cancer	0.000382	0.000656	CcSEcCtD
Fluocinolone Acetonide—Pain—Docetaxel—lung cancer	0.00038	0.000653	CcSEcCtD
Fluocinolone Acetonide—Back pain—Methotrexate—lung cancer	0.00038	0.000653	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Etoposide—lung cancer	0.000379	0.00065	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—lung cancer	0.000377	0.000647	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP2E1—lung cancer	0.000376	0.0269	CrCbGaD
Fluocinolone Acetonide—Nausea—Gemcitabine—lung cancer	0.000372	0.000639	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Cisplatin—lung cancer	0.000372	0.000638	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Paclitaxel—lung cancer	0.000371	0.000638	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1A1—lung cancer	0.000371	0.0265	CrCbGaD
Fluocinolone Acetonide—Vision blurred—Methotrexate—lung cancer	0.00037	0.000636	CcSEcCtD
Fluocinolone Acetonide—Rash—Cisplatin—lung cancer	0.000368	0.000633	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Cisplatin—lung cancer	0.000368	0.000632	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Etoposide—lung cancer	0.000366	0.000629	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—lung cancer	0.000365	0.000627	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Paclitaxel—lung cancer	0.000359	0.000617	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Etoposide—lung cancer	0.000354	0.000608	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Methotrexate—lung cancer	0.000353	0.000606	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—lung cancer	0.000352	0.000605	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Docetaxel—lung cancer	0.000352	0.000604	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Paclitaxel—lung cancer	0.000347	0.000596	CcSEcCtD
Fluocinolone Acetonide—Nausea—Cisplatin—lung cancer	0.000347	0.000596	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—ABCB1—lung cancer	0.000346	0.0247	CrCbGaD
Fluocinolone Acetonide—Alopecia—Doxorubicin—lung cancer	0.000345	0.000593	CcSEcCtD
Fluocinolone Acetonide—Cough—Methotrexate—lung cancer	0.000343	0.000589	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—lung cancer	0.000342	0.000588	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Etoposide—lung cancer	0.00034	0.000584	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—lung cancer	0.00034	0.000584	CcSEcCtD
Fluocinolone Acetonide—Erythema—Doxorubicin—lung cancer	0.00034	0.000584	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—ABCB1—lung cancer	0.000339	0.0242	CrCbGaD
Fluocinolone Acetonide—Rash—Etoposide—lung cancer	0.000338	0.00058	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Etoposide—lung cancer	0.000337	0.000579	CcSEcCtD
Fluocinolone Acetonide—Headache—Etoposide—lung cancer	0.000335	0.000576	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Methotrexate—lung cancer	0.000335	0.000574	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Paclitaxel—lung cancer	0.000334	0.000573	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—lung cancer	0.000333	0.000572	CcSEcCtD
Fluocinolone Acetonide—Rash—Paclitaxel—lung cancer	0.000331	0.000568	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Paclitaxel—lung cancer	0.000331	0.000568	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—lung cancer	0.000329	0.000565	CcSEcCtD
Fluocinolone Acetonide—Headache—Paclitaxel—lung cancer	0.000329	0.000565	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Docetaxel—lung cancer	0.000328	0.000563	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—lung cancer	0.000321	0.00055	CcSEcCtD
Fluocinolone Acetonide—Infection—Methotrexate—lung cancer	0.000319	0.000547	CcSEcCtD
Fluocinolone Acetonide—Nausea—Etoposide—lung cancer	0.000318	0.000546	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Docetaxel—lung cancer	0.000315	0.00054	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Methotrexate—lung cancer	0.000314	0.00054	CcSEcCtD
Fluocinolone Acetonide—Nausea—Paclitaxel—lung cancer	0.000312	0.000535	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.00031	0.000936	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	0.000309	0.000933	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000306	0.000926	CbGpPWpGaD
Fluocinolone Acetonide—Vertigo—Doxorubicin—lung cancer	0.000306	0.000525	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AXL—lung cancer	0.000305	0.000923	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000305	0.000922	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000305	0.000921	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MYC—lung cancer	0.000305	0.000921	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—ALB—lung cancer	0.000305	0.000921	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Docetaxel—lung cancer	0.000304	0.000523	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000304	0.00092	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—KHSRP—lung cancer	0.000304	0.000919	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.0003	0.000905	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Doxorubicin—lung cancer	0.000297	0.00051	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Docetaxel—lung cancer	0.000294	0.000505	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000292	0.000502	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CNDP2—lung cancer	0.000292	0.000882	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM2—lung cancer	0.000292	0.000882	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—lung cancer	0.00029	0.000497	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTMR3—lung cancer	0.000284	0.000858	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Docetaxel—lung cancer	0.000283	0.000486	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000282	0.000851	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—KRAS—lung cancer	0.000282	0.000851	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Docetaxel—lung cancer	0.000281	0.000482	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Docetaxel—lung cancer	0.00028	0.000481	CcSEcCtD
Fluocinolone Acetonide—Headache—Docetaxel—lung cancer	0.000279	0.000479	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000278	0.00084	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Doxorubicin—lung cancer	0.000278	0.000477	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000277	0.000475	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PGAM1—lung cancer	0.000277	0.000836	CbGpPWpGaD
Fluocinolone Acetonide—Infection—Doxorubicin—lung cancer	0.000276	0.000474	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—RAF1—lung cancer	0.000275	0.000833	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—OXTR—lung cancer	0.000274	0.000829	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRP—lung cancer	0.000274	0.000829	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Methotrexate—lung cancer	0.000274	0.000471	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—lung cancer	0.000272	0.000468	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000271	0.000818	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.00027	0.000816	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	0.000269	0.000813	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ITGB1—lung cancer	0.000266	0.000805	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000266	0.000803	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Docetaxel—lung cancer	0.000264	0.000454	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2A7—lung cancer	0.000264	0.000798	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000262	0.000791	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000261	0.00079	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—lung cancer	0.000259	0.000782	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SDC4—lung cancer	0.000258	0.000781	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000258	0.000779	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNG11—lung cancer	0.000257	0.000776	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000255	0.000772	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Methotrexate—lung cancer	0.000253	0.000435	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000253	0.000434	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000252	0.000762	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000249	0.000753	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.000248	0.00075	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IL2—lung cancer	0.000247	0.000747	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000242	0.000732	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000242	0.000731	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000242	0.000731	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DICER1—lung cancer	0.00024	0.000726	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.00024	0.000412	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—HRAS—lung cancer	0.000239	0.000723	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CA—lung cancer	0.000239	0.000722	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Doxorubicin—lung cancer	0.000237	0.000408	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—COL4A2—lung cancer	0.000237	0.000718	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Methotrexate—lung cancer	0.000236	0.000406	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000236	0.000713	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—RRM1—lung cancer	0.000235	0.000711	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA3—lung cancer	0.000235	0.000711	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—lung cancer	0.000232	0.0166	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GIPR—lung cancer	0.000231	0.000699	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000231	0.000699	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADCY1—lung cancer	0.000231	0.000698	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000227	0.000686	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Methotrexate—lung cancer	0.000227	0.00039	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PPP2R1B—lung cancer	0.000225	0.00068	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—STAT3—lung cancer	0.000225	0.00068	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000225	0.000679	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000223	0.000675	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—B4GALT5—lung cancer	0.000221	0.000669	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—lung cancer	0.000219	0.000377	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Methotrexate—lung cancer	0.000219	0.000377	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.000217	0.000656	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SDC4—lung cancer	0.000216	0.000653	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SRC—lung cancer	0.000216	0.000652	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA4—lung cancer	0.000215	0.00065	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PTHLH—lung cancer	0.000215	0.000649	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000212	0.000642	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Methotrexate—lung cancer	0.000212	0.000364	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DUSP3—lung cancer	0.000212	0.00064	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000212	0.00064	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.00021	0.000636	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—lung cancer	0.00021	0.000635	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA2—lung cancer	0.00021	0.000634	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000209	0.000633	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RHEB—lung cancer	0.000208	0.000627	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SKI—lung cancer	0.000207	0.000627	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000207	0.000626	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MMP1—lung cancer	0.000207	0.000626	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—lung cancer	0.000205	0.000351	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Methotrexate—lung cancer	0.000204	0.00035	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA1—lung cancer	0.000202	0.000612	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Methotrexate—lung cancer	0.000202	0.000347	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Methotrexate—lung cancer	0.000202	0.000347	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ANXA1—lung cancer	0.000202	0.00061	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Methotrexate—lung cancer	0.000201	0.000345	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.000201	0.000606	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCC3—lung cancer	0.0002	0.000605	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—lung cancer	0.000199	0.0006	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOA1—lung cancer	0.000198	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—ABCB1—lung cancer	0.000197	0.0141	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM8—lung cancer	0.000197	0.000595	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Doxorubicin—lung cancer	0.000196	0.000337	CcSEcCtD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000196	0.000593	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1C1—lung cancer	0.000194	0.000586	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—APP—lung cancer	0.000191	0.000578	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SKI—lung cancer	0.000191	0.000576	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Methotrexate—lung cancer	0.00019	0.000327	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—lung cancer	0.00019	0.000326	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—UGT1A1—lung cancer	0.000188	0.000569	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	0.000184	0.000557	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Doxorubicin—lung cancer	0.000184	0.000315	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNG11—lung cancer	0.000181	0.000548	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CG—lung cancer	0.000181	0.000547	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.00018	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EGF—lung cancer	0.000179	0.000541	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	0.000178	0.000539	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Doxorubicin—lung cancer	0.000177	0.000303	CcSEcCtD
Fluocinolone Acetonide—Rash—Doxorubicin—lung cancer	0.000175	0.000301	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—lung cancer	0.000175	0.0003	CcSEcCtD
Fluocinolone Acetonide—Headache—Doxorubicin—lung cancer	0.000174	0.000299	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDOA—lung cancer	0.000173	0.000522	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CREBBP—lung cancer	0.000168	0.000507	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA3—lung cancer	0.000168	0.000507	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RARB—lung cancer	0.000166	0.000503	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PXN—lung cancer	0.000165	0.0005	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Doxorubicin—lung cancer	0.000165	0.000283	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000165	0.000498	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	0.000164	0.000496	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ADCY1—lung cancer	0.000163	0.000493	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG2—lung cancer	0.000163	0.000493	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NPPA—lung cancer	0.000162	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRP—lung cancer	0.000162	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1C1—lung cancer	0.000162	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—OXTR—lung cancer	0.000162	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ENO2—lung cancer	0.00016	0.000483	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HPGDS—lung cancer	0.00016	0.000483	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CD—lung cancer	0.000159	0.000481	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPP2R1B—lung cancer	0.000159	0.00048	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—lung cancer	0.000157	0.000475	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—lung cancer	0.000157	0.000475	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000157	0.000474	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—lung cancer	0.000155	0.000469	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCLC—lung cancer	0.000153	0.000463	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2A6—lung cancer	0.000153	0.000463	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000153	0.000462	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNG11—lung cancer	0.000152	0.000458	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	0.000151	0.000455	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AVP—lung cancer	0.000149	0.00045	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ENO1—lung cancer	0.000145	0.000439	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000145	0.000438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFC—lung cancer	0.000144	0.000436	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000143	0.000432	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RAF1—lung cancer	0.000142	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPB1—lung cancer	0.00014	0.000422	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CB—lung cancer	0.000139	0.000419	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADCY1—lung cancer	0.000136	0.000412	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000136	0.00041	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—lung cancer	0.000134	0.000405	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SMARCA4—lung cancer	0.000133	0.000402	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPP2R1B—lung cancer	0.000133	0.000402	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2E1—lung cancer	0.00013	0.000394	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NQO1—lung cancer	0.000129	0.00039	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	0.000129	0.000389	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HSPB1—lung cancer	0.000128	0.000388	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—lung cancer	0.000127	0.000385	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTHLH—lung cancer	0.000127	0.000383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.000126	0.000382	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000125	0.000378	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH3—lung cancer	0.000123	0.000372	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ANXA1—lung cancer	0.000119	0.00036	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—JUNB—lung cancer	0.000116	0.000352	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—STK11—lung cancer	0.000116	0.000351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FLT1—lung cancer	0.000115	0.000349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EP300—lung cancer	0.000114	0.000345	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH3—lung cancer	0.000113	0.000342	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APP—lung cancer	0.000113	0.000342	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF9—lung cancer	0.000112	0.000339	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SRC—lung cancer	0.000111	0.000336	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000109	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—lung cancer	0.000108	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—lung cancer	0.000108	0.000325	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUNB—lung cancer	0.000107	0.000323	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NRAS—lung cancer	0.000107	0.000323	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAT—lung cancer	0.000105	0.000316	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000104	0.000314	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—lung cancer	0.000104	0.000314	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—lung cancer	0.000102	0.000309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCB1—lung cancer	0.000102	0.000308	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TYMS—lung cancer	9.99e-05	0.000302	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—lung cancer	9.88e-05	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—lung cancer	9.88e-05	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STK11—lung cancer	9.72e-05	0.000294	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6R—lung cancer	9.64e-05	0.000291	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FOXO3—lung cancer	9.38e-05	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A1—lung cancer	9.37e-05	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ERCC2—lung cancer	9.29e-05	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—lung cancer	9.2e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAP2K1—lung cancer	9.19e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CD—lung cancer	9.13e-05	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AVP—lung cancer	8.79e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—lung cancer	8.46e-05	0.000256	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ERCC2—lung cancer	8.45e-05	0.000256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—lung cancer	8.45e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HES1—lung cancer	8.31e-05	0.000251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—lung cancer	8.18e-05	0.000247	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RAF1—lung cancer	8.15e-05	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA1—lung cancer	8.04e-05	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CB—lung cancer	7.96e-05	0.000241	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—lung cancer	7.82e-05	0.000236	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.69e-05	0.000233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—lung cancer	7.65e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—lung cancer	7.63e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB3—lung cancer	7.6e-05	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—lung cancer	7.34e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—lung cancer	7.31e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TERT—lung cancer	7.28e-05	0.00022	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR1—lung cancer	7.07e-05	0.000214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—lung cancer	6.98e-05	0.000211	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—lung cancer	6.96e-05	0.00021	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—lung cancer	6.9e-05	0.000209	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CREBBP—lung cancer	6.8e-05	0.000206	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA1—lung cancer	6.72e-05	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—lung cancer	6.66e-05	0.000201	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CD—lung cancer	6.45e-05	0.000195	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—lung cancer	6.37e-05	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CREBBP—lung cancer	6.19e-05	0.000187	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—lung cancer	6.13e-05	0.000185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KIT—lung cancer	6.13e-05	0.000185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—lung cancer	6.13e-05	0.000185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NRAS—lung cancer	6.13e-05	0.000185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGF—lung cancer	6.06e-05	0.000183	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—lung cancer	5.87e-05	0.000178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—lung cancer	5.84e-05	0.000177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BRAF—lung cancer	5.77e-05	0.000174	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6R—lung cancer	5.7e-05	0.000172	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CREBBP—lung cancer	5.69e-05	0.000172	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CB—lung cancer	5.62e-05	0.00017	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—lung cancer	5.59e-05	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—lung cancer	5.57e-05	0.000168	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAP2K1—lung cancer	5.43e-05	0.000164	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CD—lung cancer	5.39e-05	0.000163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—lung cancer	5.28e-05	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—lung cancer	4.86e-05	0.000147	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—lung cancer	4.85e-05	0.000147	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDM2—lung cancer	4.83e-05	0.000146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RAF1—lung cancer	4.81e-05	0.000146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—lung cancer	4.76e-05	0.000144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CB—lung cancer	4.7e-05	0.000142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTOR—lung cancer	4.7e-05	0.000142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—EP300—lung cancer	4.63e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—lung cancer	4.52e-05	0.000137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—lung cancer	4.49e-05	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—lung cancer	4.32e-05	0.000131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—lung cancer	4.32e-05	0.00013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—lung cancer	4.3e-05	0.00013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—lung cancer	4.21e-05	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUN—lung cancer	4.2e-05	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—lung cancer	4.09e-05	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1A—lung cancer	4.07e-05	0.000123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—lung cancer	4.06e-05	0.000123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—lung cancer	3.96e-05	0.00012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EP300—lung cancer	3.87e-05	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—lung cancer	3.78e-05	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SRC—lung cancer	3.77e-05	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—lung cancer	3.67e-05	0.000111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—lung cancer	3.67e-05	0.000111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—lung cancer	3.63e-05	0.00011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NRAS—lung cancer	3.62e-05	0.00011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—lung cancer	3.47e-05	0.000105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—lung cancer	3.43e-05	0.000104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—lung cancer	3.38e-05	0.000102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—lung cancer	3.3e-05	9.98e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—lung cancer	3.12e-05	9.43e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—lung cancer	2.87e-05	8.66e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—lung cancer	2.8e-05	8.46e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—lung cancer	2.77e-05	8.38e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—lung cancer	2.65e-05	8.01e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—lung cancer	2.55e-05	7.7e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—lung cancer	2.54e-05	7.67e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—lung cancer	2.34e-05	7.08e-05	CbGpPWpGaD
